A general representation of the hybridoma method used to produce monoclonal antibodies.
Hybridoma technology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies). This process starts by injecting a mouse (or other mammal) with an antigen that provokes an immune response. A type of white blood cell, the B cell, produces antibodies that bind to the injected antigen. These antibody producing B-cells are then harvested from the mouse and, in turn, fused with immortal myeloma cancer cells (myeloma cells are cancerous plasma cells; plasma cells are derived from activated B cells), to produce a hybrid cell line called a hybridoma, which has both the antibody-producing ability of the B-cell and the longevity and reproductivity of the myeloma. The hybridomas can be grown in culture, each culture starting with one viable hybridoma cell, producing cultures each of which consists of genetically identical hybridomas which produce one antibody per culture (monoclonal) rather than mixtures of different antibodies (polyclonal). The myeloma cell line that is used in this process is selected for its ability to grow in tissue culture and for an absence of antibody synthesis. In contrast to polyclonal antibodies, which are mixtures of many different antibody molecules, the monoclonal antibodies produced by each hybridoma line are all chemically identical.
The production of monoclonal antibodies was invented by César Milstein and Georges J. F. Köhler in 1975. They shared the Nobel Prize of 1984 for Medicine and Physiology with Niels Kaj Jerne, who made other contributions to immunology. The term hybridoma was coined by Leonard Herzenberg during his sabbatical in César Milstein's laboratory in 1976–1977.[1]
^Milstein, C (1999). "The hybridoma revolution: an offshoot of basic research". BioEssays. 21 (11): 966–73. doi:10.1002/(SICI)1521-1878(199911)21:11<966::AID-BIES9>3.0.CO;2-Z. PMID 10517870.
and 24 Related for: Hybridoma technology information
Hybridomatechnology is a method for producing large numbers of identical antibodies (also called monoclonal antibodies). This process starts by injecting...
single plasma cell interrogation technologies. Different from traditional hybridomatechnology, the newer technologies use molecular biology techniques...
medicine and research. In contrast to monoclonal antibodies produced by hybridomatechnology, which may lose the capacity to produce the desired antibody over...
also includes genetic engineering, as well as cell and tissue culture technologies. The American Chemical Society defines biotechnology as the application...
fusion is production of monoclonal antibodies in hybridomatechnology, where hybrid cell lines (hybridomas) are formed by fusing specific antibody-producing...
experimental fusion of two genetically different cells, as e.g., in hybridomatechnology. Heterokaryon is from neo-classic Greek hetero, meaning different...
degradation of chromosome ends during DNA replication in eukaryotes. Hybridomatechnology, specifically used for generating immortalised antibody-producing...
off bacteria and viruses, but they are "custom-designed" (using hybridomatechnology or other methods) and can therefore be made specifically to counteract...
reactions and sometimes anaphylactic shock. Hybridomatechnology has been replaced by recombinant DNA technology, transgenic mice and phage display. To reduce...
for preparation of monoclonal antibodies. This process is called hybridomatechnology. Laboratory animals (e.g., mice) are first exposed to an antigen...
Hybridoma Bank (DSHB) is a National Resource established by the National Institutes of Health (NIH) in 1986 to bank and distribute at cost hybridomas...
creation of hybridomatechnology, and the new era of monoclonal antibodies (MoAbs) came. In 1983, Milstein and Cuello created hybrid-hybridoma (quadroma)...
same epitope with high specificity. They can be produced with the Hybridomatechnology, which allows the production of mAbs in large quantities. mAbs against...
antitoxins. The principle of monoclonal antibody production, called hybridomatechnology, was published in 1975 by Georges Köhler and César Milstein, who...
after the development of mouse hybridomatechnology in the 1970s. Research was conducted into mouse-rabbit hetero-hybridomas to make rabbit monoclonal antibodies...
oxygen uptake and lactate production rates. With the introduction of hybridomatechnology in 1975, cell culture could be applied towards the generation of...
Milstein generated the first monoclonal antibodies using their own hybridomatechnology. They started the field of monoclonal antibody development and won...
method of producing antibodies involving human–mouse hybrid cells, or hybridomas. They fused "mouse myeloma cells secreting immunoglobulin of known specificity...
murine monoclonal antibodies that recognize the C-lobe of GPC3 by hybridomatechnology. These antibodies have been humanized (e.g. hYP7) via antibody engineering...
Global Information